ROBERT ILOWITE
Physician in Millstone, NJ

License number
Pennsylvania OS008502L
Category
Osteopathic Medicine
Type
Osteopathic Physician and Surgeon
Address
Address 2
Millstone, NJ 08844
Pennsylvania

Personal information

See more information about ROBERT ILOWITE at radaris.com
Name
Address
Phone
Robert Ilowite
38 Mary Lynn Ln, Somerville, NJ 08876
Robert Ilowite
38 Mary Lynn Ln, Somerville, NJ 08876
Robert Ilowite
505 Omni Dr, Hillsborough, NJ 08844
Robert Ilowite
12 Greenwood Ct, Somerville, NJ 08876
Robert Ilowite
403 Omni Dr, Somerville, NJ 08876

Organization information

See more information about ROBERT ILOWITE at bizstanding.com

Dermatology Center - Robert Ilowite Do

505 Omni Dr, Hillsborough, NJ 08844

Categories:
Dermatology Physicians & Surgeons, Osteopathic Physicians & Surgeons, Physicians & Surgeons
Phone:
(908) 359-6685 (Phone)
Specialties:
Dermatology
Products:
Spider Vein Treatments
Payment options:
All Major Cards Accepted, American Express, Diner's Club, ...
Additional:
Medicare & Medigap

Professional information

See more information about ROBERT ILOWITE at trustoria.com
Robert K Ilowite Photo 1
Dr. Robert K Ilowite, Hillsborough NJ - DO (Doctor of Osteopathic Medicine)

Dr. Robert K Ilowite, Hillsborough NJ - DO (Doctor of Osteopathic Medicine)

Specialties:
Dermatology
Address:
Dermatology Center
505 Omni Dr, Hillsborough 08844
(908) 359-6685 (Phone)
Certifications:
Dermatology
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Dermatology Center
505 Omni Dr, Hillsborough 08844
Hunterdon Medical Center
2100 Wescott Dr, Flemington 08822
Education:
Medical School
Philadelphia College of Osteopathic Medicine
Graduated: 1992


Robert Ilowite Photo 2
Methods Of Treating Subclinical Sun Damage

Methods Of Treating Subclinical Sun Damage

US Patent:
2011030, Dec 8, 2011
Filed:
Jan 18, 2011
Appl. No.:
13/008539
Inventors:
Robert K. Ilowite - Hillsborough NJ, US
International Classification:
A61K 31/7072, A61P 17/02, A61K 31/513
US Classification:
514 51, 514274, 514 50
Abstract:
Provided are methods of treating subclinical sun damage and of inducing a chemocytotoxic response in skin. Methods of treating subclinical sun damage include the steps of: topically administering to skin of a patient a composition comprising a chemocytotoxic agent in an amount effective to induce erythema, scaling, crusting, or combinations thereof and resolve at least a portion of the subclinical sun damage, where the skin has a condition of no clinical sign of sun damage and the patient was not previously treated for actinic keratosis or nonmelanoma skin cancer. The chemocytotoxic agent can comprise a fluorinated pyrimidine antimetabolite such as 5-fluorouracil (FU), 5-fluorouridine (FUR), 5-fluorouridine-5′-monophosphate (FUMP), 5-fluorodeoxyuridine (FUdR), 5-fluorodeoxyuridine-5′-monophosphate (FdUMP), or combinations thereof.